187 related articles for article (PubMed ID: 36329348)
1. Cost-effectiveness of minimally invasive partial nephrectomy and percutaneous cryoablation for cT1a renal cell carcinoma.
Wu X; Uhlig J; Shuch BM; Uhlig A; Kim HS
Eur Radiol; 2023 Mar; 33(3):1801-1811. PubMed ID: 36329348
[TBL] [Abstract][Full Text] [Related]
2. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
3. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous cryoablation versus partial nephrectomy for cT1b renal tumors: An inverse probability weight analysis.
Aikawa K; Yanagisawa T; Fukuokaya W; Shimizu K; Miyajima K; Nakazono M; Iwatani K; Matsukawa A; Obayashi K; Kimura S; Tsuzuki S; Sasaki H; Abe H; Sadaoka S; Miki J; Kimura T
Urol Oncol; 2023 Mar; 41(3):150.e11-150.e19. PubMed ID: 36604229
[TBL] [Abstract][Full Text] [Related]
5. Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis.
Bhindi B; Mason RJ; Haddad MM; Boorjian SA; Leibovich BC; Atwell TD; Weisbrod AJ; Schmit GD; Thompson RH
Eur Urol; 2018 Feb; 73(2):254-259. PubMed ID: 28967553
[TBL] [Abstract][Full Text] [Related]
6. Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass.
Mason RJ; Atwell TD; Lohse C; Bhindi B; Weisbrod A; Boorjian SA; Leibovich BC; Schmit GD; Thompson RH
BJU Int; 2017 Oct; 120(4):544-549. PubMed ID: 28548236
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation.
Bang HJ; Littrup PJ; Goodrich DJ; Currier BP; Aoun HD; Heilbrun LK; Vaishampayan U; Adam B; Goodman AC
J Vasc Interv Radiol; 2012 Jun; 23(6):770-7. PubMed ID: 22538119
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous Cryoablation for Stage 1 Renal Cell Carcinoma: Outcomes from a 10-year Prospective Study and Comparison with Matched Cohorts from the National Cancer Database.
Morkos J; Porosnicu Rodriguez KA; Zhou A; Kolarich AR; Frangakis C; Rodriguez R; Georgiades CS
Radiology; 2020 Aug; 296(2):452-459. PubMed ID: 32515677
[TBL] [Abstract][Full Text] [Related]
9. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
[TBL] [Abstract][Full Text] [Related]
10. Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis.
Yanagisawa T; Mori K; Kawada T; Motlagh RS; Mostafaei H; Quhal F; Laukhtina E; Rajwa P; Aydh A; König F; Pallauf M; Pradere B; Miki J; Kimura T; Egawa S; Shariat SF
Urol Oncol; 2022 Jul; 40(7):315-330. PubMed ID: 35562311
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic and Clinical Outcomes of Robot-assisted Partial Nephrectomy
Uemura T; Kato T; Nagahara A; Kawashima A; Hatano K; Ujike T; Ono Y; Higashihara H; Fujita K; Fukuhara S; Kiuchi H; Imamura R; Tomiyama N; Nonomura N; Uemura M
In Vivo; 2021; 35(3):1573-1579. PubMed ID: 33910838
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis.
Pandharipande PV; Gervais DA; Mueller PR; Hur C; Gazelle GS
Radiology; 2008 Jul; 248(1):169-78. PubMed ID: 18458248
[TBL] [Abstract][Full Text] [Related]
14. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
[TBL] [Abstract][Full Text] [Related]
15. Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: An inverse probability of treatment weighting analysis.
Shi L; He Y; Liu C; Qian X; Wang Z
Cancer Med; 2020 Nov; 9(21):7988-8003. PubMed ID: 32888392
[TBL] [Abstract][Full Text] [Related]
16. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care.
Sterling J; Rivera-Núñez Z; Patel HV; Farber NJ; Kim S; Radadia KD; Modi PK; Goyal S; Parikh R; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Clin Genitourin Cancer; 2020 Dec; 18(6):e643-e650. PubMed ID: 32389458
[TBL] [Abstract][Full Text] [Related]
18. Impact of Partial Nephrectomy and Percutaneous Cryoablation on Short-term Health-related Quality of Life-A Prospective Comparative Cohort Study.
Junker T; Duus L; Rasmussen BSB; Azawi N; Lund L; Nørgaard B; Graumann O
Eur Urol Open Sci; 2022 Nov; 45():99-107. PubMed ID: 36353658
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous Ablation Versus Surgical Resection for Local Recurrence Following Partial Nephrectomy for Renal Cell Cancer: A Propensity Score Analysis (REPART Study-UroCCR 71).
Brassier M; Khene ZE; Bernhard JC; Dang VT; Ouzaid I; Nouhaud FX; Olivier J; Nedelcu C; Grenier N; Beuzit L; Doumerc N; Bensalah K; Bigot P;
Eur Urol Focus; 2022 Jan; 8(1):210-216. PubMed ID: 33622625
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis: percutaneous microwave ablation vs robotic-assisted partial nephrectomy for small renal masses.
Yeaman C; Marchant R; Lobo JM; DeNovio A; O'Connor L; Wanchek T; Ballantyne C; Lambert DL; Mithqal A; Schenkman N
Abdom Radiol (NY); 2023 Jan; 48(1):411-417. PubMed ID: 36210369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
